---
figid: PMC7589708__ijms-21-07697-g001
figtitle: Canonical Wnt signalling pathway
organisms:
- herbal medicine
- Salvia miltiorrhiza
- Homo sapiens
- Mus musculus
- Xenopus laevis
organisms_ner:
- Mus musculus
- Homo sapiens
- Xenopus laevis
- Drosophila melanogaster
pmcid: PMC7589708
filename: ijms-21-07697-g001.jpg
figlink: pmc/articles/PMC7589708/figure/ijms-21-07697-f001/
number: F1
caption: 'The Canonical Wnt signalling pathway. (a) OFF STATE. In the absence of Wnt
  ligands, β-catenin moves to the “destruction complex” consisting of casein kinase
  1α (CK1α), glycogen synthase kinase 3 β (GSK-3β) and two scaffolds: axis Inhibition
  (Axin), and adenomatous polyposis coli (APC). β-catenin undergoes phosphorylation
  at Ser45 residue by CK1α and at Ser33, Ser37 and Thr41 residues by GSK-3β. Then,
  the E3 ubiquitin ligase β-transducin repeat-containing protein (βTrCP) marks β-catenin
  ubiquitination and proteasomal degradation. This prevents β-catenin nuclear accumulation
  while allowing chromatin compaction and Groucho-mediated promoter repression. (b)
  ON STATE. The Wnt ligands bind to frizzled (FZD) receptor and the low-density-lipoprotein-related
  protein 5/6 (LRP5/LRP6); this results in dishevelled (DVL) phosphorylation and β-catenin
  release from the “destruction complex”, allowing β-catenin accumulation and nuclear
  translocation. In the nucleus, the Groucho repressor undergoes displacement, allowing
  β-catenin to interact with T-cell factor/lymphoid enhancer factor (TCF/LEF), chromatin
  remodeling and transcription of genes such as c-myc and cyclin D1.'
papertitle: 'The Wnt Signalling Pathway: A Tailored Target in Cancer.'
reftext: Malvina Koni, et al. Int J Mol Sci. 2020 Oct;21(20):7697.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9322708
figid_alias: PMC7589708__F1
figtype: Figure
redirect_from: /figures/PMC7589708__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7589708__ijms-21-07697-g001.html
  '@type': Dataset
  description: 'The Canonical Wnt signalling pathway. (a) OFF STATE. In the absence
    of Wnt ligands, β-catenin moves to the “destruction complex” consisting of casein
    kinase 1α (CK1α), glycogen synthase kinase 3 β (GSK-3β) and two scaffolds: axis
    Inhibition (Axin), and adenomatous polyposis coli (APC). β-catenin undergoes phosphorylation
    at Ser45 residue by CK1α and at Ser33, Ser37 and Thr41 residues by GSK-3β. Then,
    the E3 ubiquitin ligase β-transducin repeat-containing protein (βTrCP) marks β-catenin
    ubiquitination and proteasomal degradation. This prevents β-catenin nuclear accumulation
    while allowing chromatin compaction and Groucho-mediated promoter repression.
    (b) ON STATE. The Wnt ligands bind to frizzled (FZD) receptor and the low-density-lipoprotein-related
    protein 5/6 (LRP5/LRP6); this results in dishevelled (DVL) phosphorylation and
    β-catenin release from the “destruction complex”, allowing β-catenin accumulation
    and nuclear translocation. In the nucleus, the Groucho repressor undergoes displacement,
    allowing β-catenin to interact with T-cell factor/lymphoid enhancer factor (TCF/LEF),
    chromatin remodeling and transcription of genes such as c-myc and cyclin D1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Apc
  - Axin1
  - Dvl1
  - Lrp5
  - Myc
  - Nol3
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - KRT10
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - LRP5
  - STRCP1
  - MYC
  - apc.L
  - axin1.S
  - dvl2.L
  - dvl2.S
  - lrp5.L
  - myc.S
  - myc.L
  - 'On'
  - 'Off'
  - Apc2
  - Axn
  - Fs(3)Apc
  - aurA
  - fz
  - dsh
  - arm
  - gro
  - APC
---
